Literature DB >> 6953272

Cancer incidence in humans: relationship to plasma lipids and relative weight.

R B Wallace, C Rost, L F Burmeister, P R Pomrehn.   

Abstract

Surveillance was done on cancers in subjects in rural Iowa for 6 years after they participated in a cardiovascular risk factor-screening program. Among 5,565 men and women 20-94 years old at screening, 131 persons were identified as having cancers. Each cancer patient was matched to a control without cancer, and differences in antecedent plasma cholesterol and triglyceride levels and relative weight were sought. Mean relative weight at screening was lower among cancer patients of both sexes than among controls. Plasma cholesterol levels were lower among male patients and higher among female patients than among controls, with the differences more prominent for those less than 60 years old at screening. In males, the lower cholesterol levels occurred only in those with neoplasms developing within 24 months of screening. The higher cholesterol levels among female patients with cancers limited to gonadal hormone-related sites were not time-dependent. Triglyceride levels were not significantly different between cancer patients and controls in any analytic group, but triglyceride levels did closely parallel cholesterol alterations. A minimum of 1% of the cohort had diagnosed cancers before the screening program.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6953272

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  15 in total

1.  Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study.

Authors:  Divya Seth; Hans Garmo; Annette Wigertz; Lars Holmberg; Niklas Hammar; Ingmar Jungner; Mats Lambe; Göran Walldius; Mieke Van Hemelrijck
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

2.  Serum total and HDL cholesterol and risk of prostate cancer.

Authors:  Alison M Mondul; Stephanie J Weinstein; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Causes Control       Date:  2011-09-14       Impact factor: 2.506

Review 3.  Plasma cholesterol, lipid lowering, and risk for cancer. An update of the results from epidemiologic studies and intervention trials.

Authors:  K J Lackner; G Schettler; W Kübler
Journal:  Klin Wochenschr       Date:  1989-09-15

4.  Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women.

Authors:  A P Høyer; G Engholm
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

5.  Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer.

Authors:  Jiyoung Ahn; Unhee Lim; Stephanie J Weinstein; Arthur Schatzkin; Richard B Hayes; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

6.  Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer.

Authors:  C C Zielinski; I Stuller; P Rausch; C Müller
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

7.  Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey.

Authors:  C G Isles; D J Hole; C R Gillis; V M Hawthorne; A F Lever
Journal:  BMJ       Date:  1989-04-08

8.  Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort.

Authors:  Alison M Mondul; Sandra L Clipp; Kathy J Helzlsouer; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2009-10-06       Impact factor: 2.506

9.  Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study.

Authors:  A M Strasak; R M Pfeiffer; L J Brant; K Rapp; W Hilbe; W Oberaigner; S Lang; W Borena; H Concin; G Diem; E Ruttmann; B Glodny; K P Pfeiffer; H Ulmer
Journal:  Ann Oncol       Date:  2009-01-22       Impact factor: 32.976

10.  Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies.

Authors:  M R Law; S G Thompson
Journal:  Cancer Causes Control       Date:  1991-07       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.